Navigation Links
Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy

Drug therapy can extend survival and improve movement in a mouse model of spinal muscular atrophy (SMA), new research shows. The study, carried out at the NIH’s National// Institute of Neurological Disorders and Stroke (NINDS), suggests that similar drugs might one day be useful for treating human SMA.

"This study shows that treatment can be effective when started after the disease appears," says Kenneth H. Fischbeck, M.D., of the NINDS, who helped lead the new study. The finding is important because most children with SMA are diagnosed after symptoms of the disease become obvious, he adds.

SMA is the most common severe hereditary neurological disease of childhood, affecting one in every 8,000-10,000 children. Babies with the most common form of the disease, called SMA type I, develop symptoms before birth or in the first few months of life and have severe muscle weakness that makes it difficult for them to breathe, eat, and move. They usually die by age two. Other forms of SMA are not as severe, but still cause significant disability. While some symptoms of SMA can be alleviated, there is currently no treatment that can change the course of the disease.

SMA is caused by mutations in a gene called SMN1. Investigators studying the genetics of SMA have found that there is another gene, called SMN2, on the same chromosome. While the normal form of SMN1 produces a full-length functional protein, most of the protein produced by SMN2 is truncated and unable to function. The relatively small amount of normal SMN protein produced by the SMN2 gene can reduce the severity of the disease. Therefore, investigators are searching for drugs that can increase the amount of normal protein produced by this gene.

The new study, directed by Dr. Fischbeck's colleague Charlotte J. Sumner, M.D., at NINDS, tested a drug called trichostatin A (TSA) that is in a class of drugs called histone deacetylase (HDAC) inhibitors. These drugs increase the a
'"/>




Page: 1 2 3

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis

Post Your Comments:
(Date:11/21/2009)... Innovative medical apparel com...rence , San Clemente, Cal...ker of breakthrough medical apparel, today announc... display at Medica 2009, a leading international t...orf, Germany. Medelita inaugurates its men,s colle...
(Date:11/20/2009)..., Pioneering Neurologist Closer to Understandin... 20 Dr. Jeremy Schmahma...ol and neurologist at the Massachusetts General Ho...ted his laboratory,s research on the new field of ...INDlink Foundation. ,, Dr. Schmahmann is an awa...
(Date:11/20/2009)... Senators and Congressmen in Co...Over their Health Care Vote , ...enators and congressmen running for re-election ne...ical guru Charlie Cook, may come to regret voting ... bill, according to a breaking Zogby International...
(Date:11/20/2009)..., WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-USNe...s on a mission to redefine what it means to be "ha...al counselor with a specialty in family counseling... Forest University, Gladding says research shows t...s to sadness and even depression during the holida...
(Date:11/20/2009)... blood pressure readings in children with chronic ...even during doctor,s office visits increasing a c...to research from Johns Hopkins Children,s Center a...pears online in the Journal of American Society of...sure measurements obtained during regular doctor v...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2
...on leaders will,convene in Arlington, Virginia, Ma...s, practical applications, and strategies for the ... technology will be used to make the,meeting highl... being,developed under the direction of the progra...
...wn as stomach fluindicate the highly contagious, f... The Association for Professionals in Infection Co... to protect families against noroviruses. , Noro...etween 24 and 48 hours after exposure. Norovirus c...
...d track record in the analysis of genomic data gen...algorithms include optimized fast mapping strategi...e genome annotation in terms of transcriptome and ...aboration with customers, successfully analyzing N...
... close to 25% primarily driven by a ...N, N.J., Jan. 31 Novo Nordisk (NYSE:,NVO), a glob...l statement,for 2007., -- Sales in local currenc...voSeven(R) increased by 10% (4% in Danish kroner)....
...Out-Patient Treatments and Services, LOS ANGELES,...om the popular series Nip/Tuck, but don,t be foole... one of the country,s most notable,cosmetic surgeo... and,Conference. He will also be available for per...
...health, the largest and most common form of fat in...aken a back seat to "bad" LDL cholesterol and,"goo...,s changing as,researchers get a grip on how trigl... they slide above 200,milligrams per deciliter of ...
Other Medicine News:Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 2Health News:Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery 3Health News:6 simple steps to protect against and stop the spread of noroviruses 2Health News:Novo Nordisk Increased Net Profit by 32% in 2007 2Health News:Dr. Gregory Buford and Top Plastic Surgeon Selected as a Keynote Speaker at Spa & Resort Expo LA Convention Center, February 23-25 2Health News:Tackling Triglycerides: 8 Ways to Solve a Big Fat Problem, From the Harvard Heart Letter 2
(Date:11/21/2009)... An urgent need for new medicines t...oping world has prompted a growing number of colla...roduct development partnerships (PDPs), and pharma...ay in a symposium at the 58th annual meeting of th...e (ASTMH), these collaborations are opening up new...
(Date:11/20/2009)... Escalon Medical Corp. (... fiscal first quarter ended September 30, 2009. ...t revenue decreased approximately $234,000, or 2.7...ed September 30, 2009 as compared to the same peri...reased net revenue of $8,434,000 compared with $8,...
(Date:11/20/2009)... The United States Court of Appeals... Court ruling yesterday, approving a settlement in...armaceutical litigation against AstraZeneca Pharma....com/cgi-bin/prnh/20080317/AQM144LOGO ) ,, The ... who purchased the pharmaceutical giant,s prostate...
Breaking Medicine Technology:ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 2ASTMH Symposium Showcases Efforts To Meet the Need for New Medicines to Treat Infectious Diseases in Developing Countries 3Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3Moms Registered Dietitian Develop the First All In One Prenatal Vitamin in a Great Tasting Drink Mix 52727 1Moms Registered Dietitian Develop the First All In One Prenatal Vitamin in a Great Tasting Drink Mix 52727 2Study finds acceptable levels of anxiety among men living with early untreated prostate cancer 52722 1Study finds acceptable levels of anxiety among men living with early untreated prostate cancer 52722 2Humans lend a hand to critically endangered waterbird 9360 1Humans lend a hand to critically endangered waterbird 9360 2
...ndash; MediQuest Therapeutics,Inc., a specialty p...ies for inflammatory and infectious diseases, toda...se III study of Vascana,– a topical formulat...he study met its primary end point and demonstrate... Intent-to-Treat patient,population. Typically, a...
...amp; SHERBROOKE, Quebec--(BUSINESS,WIRE)--Jun 26, ...l,company developing small molecule drugs for the ...es, today announced positive,results for its novel... emptying in diabetic patients with gastroparesis....ted at the American,Diabetes Association,s 67th Sc...
Other Medicine Technology:MediQuest Concludes Confirmatory Phase III Study of Raynaud’s,Therapy 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 2Tranzyme Pharma Presents Initial Phase IIa Data for its Novel,Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis 3
Double Maddox
Maddox Rod, long handle
Snellen 10' Eye Test Chart
Ultrasonic Pachymeter UP-1000
Medicine Products: